Chemed (CHE) Misses Q3 EPS by 3c, Offers Guidance

Chemed (NYSE: CHE) reported Q3 EPS of $1.48, $0.03 worse than the analyst estimate of $1.51. Revenue for the quarter came in at $358.4 million versus the consensus estimate of $360 million.

Chemed sees FY2014 EPS of $6.00-$6.05, versus the consensus of $5.95.

For earnings history and earnings-related data on Chemed (CHE) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24